Cargando…

Challenges in Combining Immunotherapy with Radiotherapy in Recurrent/Metastatic Head and Neck Cancer

SIMPLE SUMMARY: Immunotherapy offers new hope for patients with recurrent or metastatic head and neck cancer. However, only 20% of patients respond to this treatment. Combining radiotherapy in novel ways with immunotherapy can lead to synergistic effect by enabling cancer recognition by immune syste...

Descripción completa

Detalles Bibliográficos
Autores principales:	Plavc, Gaber, Jesenko, Tanja, Oražem, Miha, Strojan, Primož
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692120/ https://www.ncbi.nlm.nih.gov/pubmed/33143094 http://dx.doi.org/10.3390/cancers12113197

Ejemplares similares

Combining Radiotherapy and Immunotherapy in Definitive Treatment of Head and Neck Squamous Cell Carcinoma: Review of Current Clinical Trials
por: Plavc, Gaber, et al.
Publicado: (2020)

Influence of fat-free mass index on the survival of patients with head and neck cancer
por: Lapornik, Nina, et al.
Publicado: (2022)

Mucosal melanoma of the head and neck: a population-based study from Slovenia, 1985-2013
por: Plavc, Gaber, et al.
Publicado: (2016)

Impact of delays in radiotherapy of head and neck cancer on outcome
por: Žumer, Barbara, et al.
Publicado: (2020)

Treatment of Skin Tumors with Intratumoral Interleukin 12 Gene Electrotransfer in the Head and Neck Region: A First-in-human Clinical Trial Protocol
por: Groselj, Ales, et al.
Publicado: (2022)

Assessment of Set-up Errors in the Radiotherapy of Patients with Head and Neck Cancer: Standard Vs. Individual Head Support
por: Androjna, Sabina, et al.
Publicado: (2020)

Post-radiation xerostomia therapy with allogeneic mesenchymal stromal stem cells in patients with head and neck cancer: study protocol for phase I clinical trial
por: Strojan, Primoz, et al.
Publicado: (2023)

Combining Radiotherapy and Immunotherapy in Head and Neck Cancer
por: Runnels, Juliana, et al.
Publicado: (2023)

Swallowing Disorders After Treatment for Head and Neck Cancer
por: Pezdirec, Martina, et al.
Publicado: (2019)

Image cytometric nuclear texture features in inoperable head and neck cancer: a pilot study
por: Strojan-Flezar, Margareta, et al.
Publicado: (2011)

Neuroendocrine Carcinoma of the Larynx and Pharynx: A Clinical and Histopathological Study
por: Strojan, Primož, et al.
Publicado: (2021)

Radiotherapy and Immunotherapy for Head and Neck Cancer: Current Evidence and Challenges
por: Qian, Jack M., et al.
Publicado: (2021)

Immunotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
por: Hsieh, Ronan W., et al.
Publicado: (2021)

Role of radiotherapy in melanoma management
por: Strojan, Primoz
Publicado: (2010)

Psychological distress and nutritional status in head and neck cancer patients: a pilot study
por: Gosak, Maja, et al.
Publicado: (2020)

New Challenges in Evaluating Outcomes after Immunotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
por: Alberti, Andrea, et al.
Publicado: (2022)

Prognostic Role of Diffusion Weighted and Dynamic Contrast-enhanced MRI in Loco-regionally Advanced Head and Neck Cancer Treated with Concomitant Chemoradiotherapy
por: Garbajs, Manca, et al.
Publicado: (2019)

Effects of Electrochemotherapy on Immunologically Important Modifications in Tumor Cells
por: Kesar, Ursa, et al.
Publicado: (2023)

Immunotherapy Breakthroughs in the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
por: Borel, Christian, et al.
Publicado: (2020)

Qualitative and Quantitative Diagnosis in Head and Neck Cancer
por: López, Fernando, et al.
Publicado: (2021)

Quad-shot-immunotherapy: quad-shot radiotherapy with pembrolizumab for advanced/recurrent head and neck cancer
por: Hughes, Ryan T, et al.
Publicado: (2023)

Proton Therapy for Squamous Cell Carcinoma of the Head and Neck: Early Clinical Experience and Current Challenges †
por: Nuyts, Sandra, et al.
Publicado: (2022)

Role of radiotherapy in the treatment of metastatic head and neck cancer
por: Ordoñez, Rafael, et al.
Publicado: (2019)

The Hidden Link of Exosomes to Head and Neck Cancer
por: Teng, Yong, et al.
Publicado: (2021)

Durable complete response rates following radiotherapy and immunotherapy combination in recurrent and metastatic head and neck squamous cell carcinoma: A retrospective single‐centre cohort study
por: Khera, Raj, et al.
Publicado: (2022)

Evolving treatment paradigms in recurrent and metastatic head and neck squamous cell carcinoma: the emergence of immunotherapy
por: Faraji, Farhoud, et al.
Publicado: (2023)

The Current Role of Salvage Surgery in Recurrent Head and Neck Squamous Cell Carcinoma
por: Hamoir, Marc, et al.
Publicado: (2018)

Factors Affecting Voice Quality in Early Glottic Cancer Before and After Radiotherapy
por: Mekis, Jana, et al.
Publicado: (2019)

Review of Outcomes after Salvage Surgery for Recurrent Squamous Cell Carcinoma of the Head and Neck
por: Hartl, Dana M., et al.
Publicado: (2023)

Mechanisms of different response to ionizing irradiation in isogenic head and neck cancer cell lines
por: Todorovic, Vesna, et al.
Publicado: (2019)

Change in Voice Quality after Radiotherapy for Early Glottic Cancer
por: Mekiš, Jana, et al.
Publicado: (2022)

Advancements of radiotherapy for recurrent head and neck cancer in modern era
por: Zhang, Shu, et al.
Publicado: (2023)

Electrochemotherapy in Mucosal Cancer of the Head and Neck: A Systematic Review
por: Strojan, Primož, et al.
Publicado: (2021)

Radiotherapy–immunotherapy combinations – perspectives and challenges
por: Mondini, Michele, et al.
Publicado: (2020)

A review on the advances and challenges of immunotherapy for head and neck cancer
por: Cheng, Gang, et al.
Publicado: (2021)

The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancer
por: Tejani, Mohamedtaki A, et al.
Publicado: (2010)

Treatment of Recurrent Metastatic Head and Neck Cancer: Focus on Cetuximab
por: Patel, Akshar N., et al.
Publicado: (2012)

Oral Verrucous Carcinoma: A Diagnostic and Therapeutic Challenge
por: Kristofelc, Nejc, et al.
Publicado: (2023)

Comparison of weekly administration of cisplatin versus three courses of cisplatin 100 mg/m(2) for definitive radiochemotherapy of locally advanced head-and-neck cancers
por: Rades, Dirk, et al.
Publicado: (2016)

Multidimensional biomarker predicts disease control in response to immunotherapy in recurrent or metastatic head and neck squamous-cell carcinoma
por: Flanagan, Kevin C., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6t8t2l2e89bo8rtvbku7folhke